v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (16,194,977) $ (5,178,739)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 133,095 133,438
Change in straight-line rent receivable 45,965 17,345
Amortization of operating lease right-of-use asset 48,755 90,648
Stock-based compensation and service expense 1,422,978 254,802
(Income) loss from equity method investment (392,677) 669,777
Distribution of earnings from equity method investment 611,888
Amortization of debt issuance costs and debt discount 1,155,310 1,115,433
Change in fair market value of derivative liability (471,946) (380,758)
Loss on extinguishment of debt 9,076,587
Changes in operating assets and liabilities:    
Rent receivable (4,634) 131,700
Security deposit 17,412
Deferred leasing costs 23,732 25,052
Prepaid expense and other assets (184,630) (54,683)
Accrued liabilities and other payables 985,228 (1,176,402)
Accrued liabilities and other payables - related parties (59,846)
Operating lease obligation (48,755) (90,648)
NET CASH USED IN OPERATING ACTIVITIES (4,388,557) (3,890,993)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Payment for equity interest purchase (100,000)
Improvement of commercial real estate (35,865)
Proceeds from sale of equity method investment 788,500
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES 752,635 (100,000)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from issuance of convertible debt and warrants 3,367,750
Proceeds from issuance of convertible debt 200,000
Payments of convertible debt issuance costs (282,700)
Repayments of convertible debt (3,100,000)
Proceeds from stock subscription liability 150,000
Advance from pending sale of noncontrolling interest in subsidiary 49,972 2,022,445
Proceeds from issuance of convertible preferred stock 300,000
Payments of convertible preferred stock issuance costs (10,000)
Proceeds from issuance of common stock and warrants 475,500
Payments of offering costs (52,601)
Proceeds from equity offering 2,857,852
Disbursements for equity offering costs (138,405)
NET CASH PROVIDED BY FINANCING ACTIVITIES 1,112,871 4,726,942
EFFECT OF EXCHANGE RATE ON CASH 673 2,848
NET (DECREASE) INCREASE IN CASH (2,522,378) 738,797
CASH - beginning of period 2,856,309 285,400
CASH - end of period 333,931 1,024,197
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Interest 702,229 712,235
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Common stock issued for future services 176,485 28,879
Common stock issued for accrued liabilities 42,385 60,000
Receivable related to sale of equity method investment 1,745,000
Related party payable extinguished upon sale of equity method investment 632,916
Series B Convertible Preferred Stock extinguished related to sale of equity method investment 11,000,000
Series D Convertible Preferred Stock issued in exchange of Series A Convertible Preferred Stock 9,000,000
Warrants issued as convertible note payable finder’s fee 40,900
Warrants issued with convertible note payable recorded as debt discount 438,568
Common stock issued as convertible note payable commitment fee 26,800 320,546
Equity method investment payable paid by a related party 566,667
Reclassification of deferred offering costs 175,136
Settlement of derivative liability 176,529
Issuance of common stock upon cashless exercise of stock warrants 43
Initial ROU asset and lease liability 127,486
Conversion of convertible note payable and accrued interest into common stock 1,587,722
Deferred financing costs in accrued liabilities 57,051
Legal fees recorded to receivable from sale of equity method investment $ 50,000

Source

PDF HTML
ZIP